OHSU Innovates 2025 Impact Report
Delve into the OHSU Innovates 2025 Impact Report to discover exciting advancements in healthcare, successful startups and innovative collaborations across the university. These initiatives reflect how OHSU is strengthening Oregon’s innovation community by supporting new clinical ventures, empowering innovators, recognizing leaders in medical innovation, advancing women’s health and highlighting emerging technologies.
Learn more about OHSU Innovates
OHSU Innovates is proud to support researchers and clinicians at OHSU who are striving to turn scientific ideas into real world solutions.
Hear from a few of these OHSU members and learn what motivates them and how OHSU fosters innovation, collaboration and entrepreneurship.
Subscribe to the OHSU Innovates newsletter for the latest news, programs and events.
Featured News
OHSU research leads to FDA approval for brain cancer imaging
OHSU researchers helped secure FDA approval for ferumoxytol (FERABRIGHT™) as a contrast agent to detect and monitor brain tumors. The work began nearly 30 years ago in the lab of Edward Neuwelt, M.D., and was carried out by the Neuro-Oncology Blood-Brain Barrier Program team. Key contributors include Lisa Muir, M.P.A.,H.A., C.C.R.P., Ramon Barajas Jr., M.D., Laszlo Szidonya, M.D., Ph.D., Amy Huddleston, M.P.A., H.A., Leslie Muldoon, Ph.D., and Rochelle Fu, Ph.D.
OHSU Technology Transfer helped move the research from the lab to FDA approval, making this new imaging option available to physicians.
Read the full story from OHSU News.
Featured Event
Advancing Gene Therapy at OHSU: From Discovery to Clinical Impact
Join us Thursday, April 30, from 12–1 p.m. PT, for the first OHSU Innovates: Rare Disease Research and Translation virtual seminar, “Advancing Gene Therapy at OHSU: From Discovery to Clinical Impact.”
Learn about OHSU’s expanding gene therapy capabilities from early discovery through clinical impact. This session highlights the Gene Therapy Strategy Team and how investigators, clinicians and partners collaborate to advance promising therapies toward real-world patient benefit.
Register for this event through Zoom.
When: Thursday, April 30, 12-1 p.m. PT
Where: Virtual
Who: Open to all
Cost: Free
Featured funding opportunity
Biomedical Innovation Program (BIP) – Drug Discovery Track
The BIP Drug Discovery Track supports OHSU investigators and trainees in developing new drug discovery and therapeutic technologies. Offered by the Oregon Clinical and Translational Research Institute in partnership with OHSU Innovates, the program provides funding, project management and commercialization mentorship to help advance early-stage concepts toward real-world impact.
Awards of up to $60,000 are available for 12-month projects.
Applications are due May 5.
See the Request for Applications for full details and submission instructions. For questions or to schedule a consult, contact Jonathan Jubera, MBA, at jubera@ohsu.edu.
OHSU Innovates collaborative network
Innovate Collaborate Oregon
OHSU Innovates is a proud partner of Innovate Collaborate Oregon (ICOregon), a collaborative network of Oregon institutions, which aims to further support and encourage the growth of innovation and entrepreneurship across the state. By bringing together resources across multiple institutions ICOregon aims to promote innovative discoveries, establish successful collaborations, form new companies, and increase economic development in Oregon.
Support OHSU Innovates
Become a sponsor
Learn more about how your organization can support innovation and entrepreneurship at OHSU and across the region.
Support innovation at OHSU
Help OHSU drive regional economic impact through entrepreneurship.
Learn more about the IDEA fund.